
Ernest G. Therkorn
Examiner (ID: 12150)
| Most Active Art Unit | 1306 |
| Art Unit(s) | 1797, 1778, 1306, 1723, 1776, 2507, 1801, 2200 |
| Total Applications | 3289 |
| Issued Applications | 2312 |
| Pending Applications | 177 |
| Abandoned Applications | 801 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10498558
[patent_doc_number] => 09226948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Composition and method for the inhibition of postoperative adhesions severity'
[patent_app_type] => utility
[patent_app_number] => 13/846455
[patent_app_country] => US
[patent_app_date] => 2013-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6738
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846455
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/846455 | Composition and method for the inhibition of postoperative adhesions severity | Mar 17, 2013 | Issued |
Array
(
[id] => 9041138
[patent_doc_number] => 20130243776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/831856
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35488
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13831856
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/831856 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9041139
[patent_doc_number] => 20130243777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/831862
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35470
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13831862
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/831862 | Antibodies that bind IL-4 and/or IL-13 and their uses | Mar 14, 2013 | Issued |
Array
(
[id] => 9041140
[patent_doc_number] => 20130243778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/831884
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35492
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13831884
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/831884 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9268732
[patent_doc_number] => 20140023649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/831866
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35472
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13831866
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/831866 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9735827
[patent_doc_number] => 20140271539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'NOVEL USE OF MEMBERS OF IL-10 CYTOKINE FAMILY'
[patent_app_type] => utility
[patent_app_number] => 13/831262
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6126
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13831262
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/831262 | Use of members of IL-10 cytokine family | Mar 13, 2013 | Issued |
Array
(
[id] => 10234331
[patent_doc_number] => 20150119325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'METHODS FOR THE PRODUCTION OF CYTOPROTECTIVE ASIALO-ERYTHROPOIETIN IN PLANTS AND ITS PURIFICATION FROM PLANT TISSUES'
[patent_app_type] => utility
[patent_app_number] => 14/403231
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23624
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403231
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403231 | METHODS FOR THE PRODUCTION OF CYTOPROTECTIVE ASIALO-ERYTHROPOIETIN IN PLANTS AND ITS PURIFICATION FROM PLANT TISSUES | Mar 13, 2013 | Pending |
Array
(
[id] => 8928447
[patent_doc_number] => 20130184207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/804354
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 40244
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13804354
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/804354 | Long-acting polypeptides and methods of producing and administering same | Mar 13, 2013 | Issued |
Array
(
[id] => 9596718
[patent_doc_number] => 20140193397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/802333
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 36438
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13802333
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/802333 | METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY | Mar 12, 2013 | Abandoned |
Array
(
[id] => 9082558
[patent_doc_number] => 20130268088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'BONE SUBSTITUTE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/799959
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7677
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13799959
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/799959 | BONE SUBSTITUTE COMPOSITION | Mar 12, 2013 | |
Array
(
[id] => 9053954
[patent_doc_number] => 20130251668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'USE OF OSTEOPROTEGERIN (OPG) TO INCREASE HUMAN PANCREATIC BETA CELL SURVIVAL AND PROLIFERATION'
[patent_app_type] => utility
[patent_app_number] => 13/802159
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19982
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13802159
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/802159 | Use of osteoprotegerin (OPG) to increase human pancreatic beta cell survival and proliferation | Mar 12, 2013 | Issued |
Array
(
[id] => 9330093
[patent_doc_number] => 20140056875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/802303
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 35646
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13802303
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/802303 | METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY | Mar 12, 2013 | Abandoned |
Array
(
[id] => 9330092
[patent_doc_number] => 20140056874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/802282
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 35630
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13802282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/802282 | METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY | Mar 12, 2013 | Abandoned |
Array
(
[id] => 13105075
[patent_doc_number] => 10071166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Protein complex using an immunoglobulin fragment and method for the preparation thereof
[patent_app_type] => utility
[patent_app_number] => 13/796135
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17672
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13796135
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/796135 | Protein complex using an immunoglobulin fragment and method for the preparation thereof | Mar 11, 2013 | Issued |
Array
(
[id] => 9054003
[patent_doc_number] => 20130251717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/794310
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35490
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13794310
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/794310 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | Mar 10, 2013 | Abandoned |
Array
(
[id] => 11859056
[patent_doc_number] => 09738728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Antibodies that bind IL-4 and/or IL-13 and their uses'
[patent_app_type] => utility
[patent_app_number] => 13/794295
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35596
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 396
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13794295
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/794295 | Antibodies that bind IL-4 and/or IL-13 and their uses | Mar 10, 2013 | Issued |
Array
(
[id] => 9033823
[patent_doc_number] => 20130236461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/794341
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35486
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13794341
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/794341 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | Mar 10, 2013 | Abandoned |
Array
(
[id] => 9033825
[patent_doc_number] => 20130236463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/794370
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35489
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13794370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/794370 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | Mar 10, 2013 | Abandoned |
Array
(
[id] => 9033824
[patent_doc_number] => 20130236462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/794354
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35479
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13794354
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/794354 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | Mar 10, 2013 | Abandoned |
Array
(
[id] => 9068110
[patent_doc_number] => 20130259866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/794394
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35489
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13794394
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/794394 | ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES | Mar 10, 2013 | Abandoned |